Stoke Therapeutics (STOK) Selling, General & Administrative (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -37.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.17 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 493.70 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -1.52 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 647.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 322.55 Mn |
| 10 | Stoke Therapeutics | 1.92 Bn | 1.92 Bn | - | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.97 Mn |
| Dec 31, 2025 | 21.15 Mn |
| Sep 30, 2025 | 16.03 Mn |
| Jun 30, 2025 | 15.26 Mn |
| Mar 31, 2025 | 14.65 Mn |
| Dec 31, 2024 | 12.84 Mn |
| Sep 30, 2024 | 12.69 Mn |
| Jun 30, 2024 | 13.04 Mn |
| Mar 31, 2024 | 10.22 Mn |
| Dec 31, 2023 | 10.61 Mn |
| Sep 30, 2023 | 10.27 Mn |
| Jun 30, 2023 | 10.23 Mn |
| Mar 31, 2023 | 10.21 Mn |
| Dec 31, 2022 | 9.38 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 10.11 Mn |
| Mar 31, 2022 | 9.49 Mn |
| Dec 31, 2021 | 8.72 Mn |
| Sep 30, 2021 | 8.33 Mn |
| Jun 30, 2021 | 7.93 Mn |
| Mar 31, 2021 | 6.91 Mn |
| Dec 31, 2020 | 5.68 Mn |
| Sep 30, 2020 | 5.60 Mn |
| Jun 30, 2020 | 5.04 Mn |
| Mar 31, 2020 | 4.52 Mn |
| Dec 31, 2019 | 3.98 Mn |
| Sep 30, 2019 | 3.32 Mn |
| Jun 30, 2019 | 2.42 Mn |
| Mar 31, 2019 | 2.19 Mn |
| Dec 31, 2018 | 1.54 Mn |
| Sep 30, 2018 | 1.09 Mn |
| Jun 30, 2018 | 1.12 Mn |